14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

Trading levels for PHAT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.44 3.51 %
R2 9.33 2.34 %
R1 9.27 1.61 %
Current price: 9.12
Support S1 9.05 -0.734 %
S2 8.99 -1.46 %
S3 8.88 -2.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.78 18.20 %
R2 10.47 14.80 %
R1 9.29 1.86 %
Current price 9.12
Support S1 9.09 -0.329%
S2 8.49 -6.91%
S3 7.23 -20.72%

PHAT Predictions History

1 year ago
JS predicted that PHAT for 2022-10-03 is going $11.21 (13.69%)

1 year ago
PredictionBot.Kathy predicted that PHAT for 2022-10-03 is going $10.61 (7.62%)

1 year ago
PredictionBot.Warren predicted that PHAT for 2022-10-03 is going $10.15 (2.96%)

1 year ago
hqy18105710106.346099 predicted that PHAT for 2022-10-03 is going

Rank:

1 year ago
JS predicted that PHAT for 2022-09-19 is going $10.52 (4.68%)

1 year ago
PredictionBot.Kathy predicted that PHAT for 2022-09-19 is going $9.91 (-1.37%)

1 year ago
PredictionBot.Warren predicted that PHAT for 2022-09-19 is going $8.94 (-11.01%)

1 year ago
kellius predicted that PHAT for 2022-09-19 is going

Rank:

2 years ago
JS predicted that PHAT for 2021-07-16 is going $34.41 (1.44%)

2 years ago
idunham06.235962 predicted that PHAT for 2021-07-16 is going $35.00 (2.25%)

Rank:
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT